DE69232716T2 - Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung - Google Patents

Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung

Info

Publication number
DE69232716T2
DE69232716T2 DE69232716T DE69232716T DE69232716T2 DE 69232716 T2 DE69232716 T2 DE 69232716T2 DE 69232716 T DE69232716 T DE 69232716T DE 69232716 T DE69232716 T DE 69232716T DE 69232716 T2 DE69232716 T2 DE 69232716T2
Authority
DE
Germany
Prior art keywords
thrombospondin
peptides
activity
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232716T
Other languages
English (en)
Other versions
DE69232716D1 (de
Inventor
Jacob Eyal
George Paul Tuszynski
Bruce King Hamilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WR Grace and Co Conn
WR Grace and Co
Philadelphia Health and Education Corp
Original Assignee
WR Grace and Co Conn
WR Grace and Co
Philadelphia Health and Education Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WR Grace and Co Conn, WR Grace and Co, Philadelphia Health and Education Corp filed Critical WR Grace and Co Conn
Publication of DE69232716D1 publication Critical patent/DE69232716D1/de
Application granted granted Critical
Publication of DE69232716T2 publication Critical patent/DE69232716T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69232716T 1991-05-22 1992-05-08 Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung Expired - Fee Related DE69232716T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70525591A 1991-05-22 1991-05-22

Publications (2)

Publication Number Publication Date
DE69232716D1 DE69232716D1 (de) 2002-09-12
DE69232716T2 true DE69232716T2 (de) 2002-11-28

Family

ID=24832676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232716T Expired - Fee Related DE69232716T2 (de) 1991-05-22 1992-05-08 Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung

Country Status (7)

Country Link
US (1) US5654277A (de)
EP (1) EP0514721B1 (de)
JP (2) JP3706151B2 (de)
AU (1) AU1636492A (de)
CA (1) CA2063055A1 (de)
DE (1) DE69232716T2 (de)
ES (1) ES2181670T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
DE4203545A1 (de) * 1992-02-07 1993-08-12 Behringwerke Ag Spezifische antikoerper gegen aktivierte plaettchen, ihre herstellung und ihre verwendung in diagnose und therapie
AU5161296A (en) * 1995-04-21 1996-11-07 Allelix Biopharmaceuticals Inc. Anti-haemorrhagic peptides
AU5699996A (en) * 1995-06-02 1996-12-18 Allelix Biopharmaceuticals Inc. Anti-inflammatory thrombospondin-derived peptides
ATE307584T1 (de) * 1997-08-28 2005-11-15 Nissan Chemical Ind Ltd Mittel zur förderung und verstärkung der neovaskularisierung
WO1999061466A1 (en) * 1998-05-22 1999-12-02 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
US6716963B1 (en) 1998-05-22 2004-04-06 Abbott Laboratories Peptide antiangiogenic drugs
US6380161B1 (en) 1999-06-21 2002-04-30 Inkine Pharmaceutical Company, Inc. Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
CN1297930A (zh) * 1999-11-29 2001-06-06 上海博容基因开发有限公司 一种新的多肽——人凝血栓蛋白30和编码这种多肽的多核苷酸
US7740841B1 (en) * 2000-01-28 2010-06-22 Sunnybrook Health Science Center Therapeutic method for reducing angiogenesis
US7655411B2 (en) * 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
EP2776055B1 (de) * 2011-08-17 2016-12-14 Ironwood Pharmaceuticals, Inc. Behandlungen für magen-darm-erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5190918A (en) * 1990-02-22 1993-03-02 W. R. Grace & Co.-Conn. Peptide fragments and analogs of thrombospondin and methods of use
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
DE69132708T2 (de) * 1990-09-24 2002-06-20 Grace W R & Co Therapeutische Vervendung von Peptiden mit Thrombospondin - ähnlicher Aktivität

Also Published As

Publication number Publication date
JP2005272480A (ja) 2005-10-06
JP3706151B2 (ja) 2005-10-12
EP0514721A1 (de) 1992-11-25
DE69232716D1 (de) 2002-09-12
AU1636492A (en) 1992-11-26
US5654277A (en) 1997-08-05
ES2181670T3 (es) 2003-03-01
EP0514721B1 (de) 2002-08-07
JPH05178757A (ja) 1993-07-20
CA2063055A1 (en) 1992-11-23

Similar Documents

Publication Publication Date Title
DE68921469T2 (de) Peptidderivate und deren verwendung.
DE69132708T2 (de) Therapeutische Vervendung von Peptiden mit Thrombospondin - ähnlicher Aktivität
DK14890D0 (da) Peptider med t-hjaelpercelleaktivitet
DE69424576D1 (de) Biologisch aktive tgf-beta1 und tgf-beta2 peptide
DE4393381T1 (de) Peptide
DK0605442T3 (da) Rekombinante antistoffer til human terapi
NO924395D0 (no) Rekombinante menneske-faktor viii derivater
DE69223266T2 (de) Peptidderivate und deren Verwendung
DK6893D0 (da) Peptid
DE69232716D1 (de) Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung
SE8803847A0 (sv) Neuromodulerande peptid
DK326889A (da) Polypeptid og polypeptidkompleks samt deres anvendelse
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
ATE277948T1 (de) Bpc peptid salze mit organ-schützender aktivität, deren herstellung und therapeutische verwendung
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
DE59107525D1 (de) Peptidamidase und deren Verwendung
ATE171460T1 (de) Synthetische amphipatische peptide mit antimikrobieller wirksamkeit
NO944670D0 (no) Enkeltkjedet peptid med hemoregulatorisk aktivitet
DE69420044T2 (de) Blutregulierende peptide
DE68928271T2 (de) Polypeptid mit Isoamylase-Aktivität und seine Verwendung
NO944668D0 (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet
DE68914544D1 (de) Peptid und Wirkstoff gegen Dementia.
FI960119A0 (fi) Peptidit, joilla on oksitosiinin vastaista aktiivisuutta
DE69739053D1 (de) Polypeptid mit beta-Fructofuranosidase-Aktivität
DE68924022D1 (de) Protein mit hemmender Aktivität gegenüber menschlichem Plasmin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee